News
Health Matters: Health Canada approves Ozempic to help reduce kidney decline
Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 diabetes. The decision comes after an international clinical trial found the risk of deteriorating kidney function was 24 per cent lower in patients taking Ozempic compared to those taking a placebo injection.
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.
A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, manufacturer Novo Nordisk and Health Canada said on Friday. “We are experiencing a temporary ...
In a statement, Health Canada said its Vigilance Program received one report of “overdose” of Ozempic in March 2022 and continues to monitor the safety of Ozempic.
A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, manufacturer Novo Nordisk and Health Canada said on Friday. We are experiencing a temporary ...
Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially dangerous, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback